The mean change in A1C from baseline to Week 24 was 0.1% (95% confidence interval 0%, 0.3%) for the metformin HCl immediate-release treatment arm, 0.3% (95% confidence interval 0.1%, 0.4%) for the 1,000 mg metformin HCl extended-release treatment arm, and 0.1% (95% confidence interval 0%, 0.3%) for the 1,500 mg metformin HCl extended-release treatment arm
Once reconstituted with bacteriostatic water, the solution requires refrigeration at 2 to 8 degrees Celsius and should be used within 30 days
Additionally, the mean HbA1c reduction with survodutide at a dose of 0.9 mg was similar to that observed with semaglutide
The gastrointestinal side effects may also start to subside, contributing to improved energy levels
Ha pedig nmagban az letmdvlts nem vezet eredmnyre, els krben javasolt megvizsglni, hogy nem valamilyen httrben meghzd egszsggyi problma okozza-e a fogysi nehzsget
Key administration points for the combination: Separate injection sites: Never inject both compounds at the same anatomical location